FDA accepts priority review of gepotidacin, a first-in-class oral antibiotic, for treating uncomplicated urogenital gonorrhea in patients 12 years and older.
A new study finds that infections such as chlamydia, gonorrhea, and syphilis during pregnancy significantly increase the risk of stillbirth, preterm birth, and low birth weight.